Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission-Niger Experience.

Saved in:
Bibliographic Details
Title: Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission-Niger Experience.
Authors: Ousmane S; Centre de Recherche Médicale et Sanitaire, CERMES, Niamey, Niger., Ibrahim DD; Centre de Recherche Médicale et Sanitaire, CERMES, Niamey, Niger., Goel A; Polio Eradication Department, World Health Organization, Geneva, Switzerland., Hendley WS; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mainou BA; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Palmer T; Geospatial Research Analysis and Services Program, Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, USA., Diaha A; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Greene SA; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mach O; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2021 May 06; Vol. 8 (7), pp. ofab210. Date of Electronic Publication: 2021 May 06 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2328-8957
DOI:10.1093/ofid/ofab210